MAPK8 and glioblastoma: AaTs‐1 (4‐mer), a peptide derived from this species, inhibited glioblastoma cell proliferation, increased p53 expression, and inhibited the phosphorylation of the kinases ERK, p38, and JNK, which increases the chemosensitivity of glioblastoma cells [67].